Physician profile
Priya Arcot-Joshi
NPI 1871997866
$1,008.38
in general payments reported to CMS, 2019-2025
17 companies · $89.46 in 2025
The $89.46 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $265 · 2021: $510 · 2025: $89.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $212.56 | 2020-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $186.79 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $128.63 | 2019-2021 | |
| Shockwave Medical, INC | $125.39 | 2021 | |
| Merck Sharp & Dohme LLC | $103.36 | 2019-2020 | |
| Novo Nordisk INC | $39.39 | 2019-2021 | |
| Exact Sciences Corporation | $29.84 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $27.72 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.63 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.35 | 2021 | |
| Medtronic USA, INC. | $18.31 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $17.51 | 2020 | |
| Currax Pharmaceuticals LLC | $16.71 | 2025 | Contrave |
| Pfizer INC. | $16.06 | 2020 | |
| Amarin Pharma, INC. | $14.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.44 | 2020 | |
| Glaxosmithkline, LLC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Arcot-Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.